In this study, we investigated and found that both variants are transcribed, but they are not expressed at all, as confirmed by immunoblotting, implying that loss of TRAPPC2 function is causative for SEDT-XL phenotypes of these patients. Here, TRAPPC2 is linked to spondyloepiphyseal dysplasia tarda, X-linked.